Global Liver Cancer Drugs Market By Drug Class (Targeted Therapy, Immunotherapy, Chemotherapy and Others), By Cancer Type (Hepatocellular Carcinoma (HCC), Cholangiocarcinoma, Hepatoblastoma and Others), By Route of Administration (Oral and Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034
- Published date: Aug 2025
- Report ID: 43471
- Number of Pages: 394
- Format:
-
-
-
- Bayer AG Company Profile
- Bristol-Myers Squibb
- Merck & Co., Inc.
- Pfizer Inc Company Profile
- Exelixis, Inc.
- Eisai Co., Ltd.
- Eli Lilly and Company
- Hoffmann-La Roche Ltd
- Novartis AG Company Profile
- AstraZeneca Plc Company Profile
- Ipsen
- Sirtex Medical
- Gilead Sciences
- BeiGene
- Innovent Biologics
- Sumitomo Pharma
- Hepion Pharmaceuticals
- Others
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible